Skip to main content

Advertisement

Log in

Obstructive sleep apnea and hypertension: Mechanisms, evaluation, and management

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Obstructive sleep apnea (OSA) is a recognized cause of secondary hypertension. OSA episodes produce surges in systolic and diastolic pressure that keep mean blood pressure levels elevated at night. In many patients, blood pressure remains elevated during the daytime, when breathing is normal. Contributors to this diurnal pattern of hypertension include sympathetic nervous system overactivity and alterations in vascular function and structure caused by oxidant stress and inflammation. Treatment of OSA with nasal continuous positive airway pressure (CPAP) abolishes apneas, thereby preventing intermittent arterial pressure surges and restoring the nocturnal “dipping” pattern. CPAP treatment also has modest beneficial effects on daytime blood pressure. Because even small decreases in arterial pressure can contribute to reducing cardiovascular risk, screening for OSA is an essential element of evaluating patients with hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230–1235.

    Article  PubMed  CAS  Google Scholar 

  2. Peppard PE, Young T, Palta M, et al.: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378–1384.

    Article  PubMed  CAS  Google Scholar 

  3. Fletcher EC: Invited review: physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 2001, 90:1600–1605.

    Article  PubMed  CAS  Google Scholar 

  4. Becker HF, Jerrentrup A, Ploch T, et al.: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68–73.

    Article  PubMed  Google Scholar 

  5. Narkiewicz K, van de Borne PJ, Montano N, et al.: Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998, 97:943–945.

    PubMed  CAS  Google Scholar 

  6. Prabhakar NR, Peng YJ, Jacono FJ, et al.: Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol 2005, 32:447–449.

    Article  PubMed  CAS  Google Scholar 

  7. Lam SY, Fung ML, Leung PS: Regulation of the angiotensin-converting enzyme activity by a time-course hypoxia in the carotid body. J Appl Physiol 2004, 96:809–813.

    Article  PubMed  CAS  Google Scholar 

  8. Moller DS, Lind P, Strunge B, et al.: Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003, 16:274–280.

    Article  PubMed  CAS  Google Scholar 

  9. Peng YJ, Overholt JL, Kline D, et al.: Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc Natl Acad Sci USA 2003, 100:10073–10078.

    Article  PubMed  CAS  Google Scholar 

  10. Chen J, He L, Dinger B, et al.: Role of endothelin and endothelin A-type receptor in adaptation of the carotid body to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2002, 282:L1314–L1323.

    PubMed  CAS  Google Scholar 

  11. Grimpen F, Kanne P, Schulz E, et al.: Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J 2000, 15:320–325.

    Article  PubMed  CAS  Google Scholar 

  12. Gjorup PH, Sadauskiene L, Wessels J, et al.: Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 2007, 20:44–52.

    Article  PubMed  CAS  Google Scholar 

  13. Sun SY, Wang W, Zucker IH, et al.: Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 1999, 86:1273–1282.

    Article  PubMed  CAS  Google Scholar 

  14. Weiss JW, Liu MD, Huang J: Sleep apnoea and hypertension: physiological bases for a causal relation: physiological basis for a causal relationship of obstructive sleep apnoea to hypertension. Exp Physiol 2007, 92:21–26.

    Article  PubMed  CAS  Google Scholar 

  15. Zimmerman MC, Lazartigues E, Lang JA, et al.: Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 2002, 91:1038–1045.

    Article  PubMed  CAS  Google Scholar 

  16. Zucker IH: Brain angiotensin II: new insights into its role in sympathetic regulation. Circ Res 2002, 90:503–505.

    Article  PubMed  CAS  Google Scholar 

  17. Huang J, Tamisier R, Ji E, et al.: Chronic intermittent hypoxia modulates nNOS mRNA and protein expression in the rat hypothalamus. Respir Physiol Neurobiol 2007, 158:30–38.

    Article  PubMed  CAS  Google Scholar 

  18. Phillips SA, Olson EB, Morgan BJ, et al.: Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 2004, 286:H388–H393.

    Article  PubMed  CAS  Google Scholar 

  19. El Solh AA, Saliba R, Bosinski T, et al.: Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 2006, 27:997–1002.

    PubMed  Google Scholar 

  20. Grebe M, Eisele HJ, Weissmann N, et al.: Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006, 173:897–901.

    Article  PubMed  CAS  Google Scholar 

  21. Lattimore JL, Wilcox I, Skilton M, et al.: Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006, 61:491–495.

    Article  PubMed  CAS  Google Scholar 

  22. Ip MS, Lam B, Chan LY, et al.: Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000, 162:2166–2171.

    PubMed  CAS  Google Scholar 

  23. Schulz R, Mahmoudi S, Hattar K, et al.: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000, 162:566–570.

    PubMed  CAS  Google Scholar 

  24. Wolk R, Svatikova A, Otto ME, et al.: Plasma adrenomedullin and obstructive sleep apnea. Am J Hypertens 2004, 17:74–76.

    Article  PubMed  CAS  Google Scholar 

  25. Schulz R, Flototto C, Jahn A, et al.: Circulating adrenomedullin in obstructive sleep apnoea. J Sleep Res 2006, 15:89–95.

    Article  PubMed  Google Scholar 

  26. Yamamoto H, Teramoto S, Yamaguchi Y, et al.: Long-term oxygen administration reduces plasma adrenomedullin levels in patients with obstructive sleep apnea syndrome. Sleep Med 2007, In press.

  27. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, et al.: Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007, 131:453–459.

    Article  PubMed  CAS  Google Scholar 

  28. Tanriverdi H, Evrengul H, Kara CO, et al.: Aortic stiffness, flow-mediated dilatation and carotid intima-media thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis. Respiration 2006, 73:741–750.

    Article  PubMed  Google Scholar 

  29. Phillips C, Hedner J, Berend N, et al.: Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. Sleep 2005, 28:604–609.

    PubMed  Google Scholar 

  30. Drager LF, Bortolotto LA, Figueiredo AC, et al.: Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 2007, 131:1379–1386.

    Article  PubMed  Google Scholar 

  31. Yokoe T, Minoguchi K, Matsuo H, et al.: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003, 107:1129–1134.

    Article  PubMed  CAS  Google Scholar 

  32. Gonzalez NC, Allen J, Schmidt EJ, et al.: Role of the renin-angiotensin system in the systemic microvascular inflammation of alveolar hypoxia. Am J Physiol Heart Circ Physiol 2007, 292:H2285–H2294.

    Article  PubMed  CAS  Google Scholar 

  33. Zhao Q, Ishibashi M, Hiasa K, et al.: Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 2004, 44:264–270.

    Article  PubMed  CAS  Google Scholar 

  34. Allahdadi KJ, Walker BR, Kanagy NL: Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005, 45:705–709.

    Article  PubMed  CAS  Google Scholar 

  35. Palma BD, Gabriel A Jr, Bignotto M, et al.: Paradoxical sleep deprivation increases plasma endothelin levels. Braz J Med Biol Res 2002, 35:75–79.

    Article  PubMed  CAS  Google Scholar 

  36. Zhang J, Zhao B, Gesongluobu, et al.: Angiotensin-converting enzyme gene insertion/deletion (I/D) polymorphism in hypertensive patients with different degrees of obstructive sleep apnea. Hypertens Res 2000, 23:407–411.

    Article  PubMed  CAS  Google Scholar 

  37. Bostrom KB, Hedner J, Melander O, et al.: Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens 2007, 25:779–783.

    Article  PubMed  CAS  Google Scholar 

  38. Patel SR, Emma KL, Mignot E, et al.: The association of angiotensin converting enzyme (ACE) polymorphisms with sleep apnea and hypertension. Sleep 2007, 30:531–533.

    PubMed  Google Scholar 

  39. Sjostrom C, Lindberg E, Elmasry A, et al.: Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax 2002, 57:602–607.

    Article  PubMed  CAS  Google Scholar 

  40. Netzer NC, Stoohs RA, Netzer CM, et al.: Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999, 131:485–491.

    PubMed  CAS  Google Scholar 

  41. Calhoun DA, Nishizaka MK, Zaman MA, et al.: Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002, 40:892–896.

    Article  PubMed  CAS  Google Scholar 

  42. Amin RS, Carroll JL, Jeffries JL, et al.: Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med 2004, 169:950–956.

    Article  PubMed  Google Scholar 

  43. Leung LC, Ng DK, Lau MW, et al.: Twenty-four-hour ambulatory BP in snoring children with obstructive sleep apnea syndrome. Chest 2006, 130:1009–1017.

    Article  PubMed  Google Scholar 

  44. Zintzaras E, Kaditis AG: Sleep-disordered breathing and blood pressure in children: a meta-analysis. Arch Pediatr Adolesc Med 2007, 161:172–178.

    Article  PubMed  Google Scholar 

  45. Heitmann J, Ehlenz K, Penzel T, et al.: Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004, 23:255–262.

    Article  PubMed  CAS  Google Scholar 

  46. Norman D, Loredo JS, Nelesen RA, et al.: Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006, 47:840–845.

    Article  PubMed  CAS  Google Scholar 

  47. Robinson GV, Smith DM, Langford BA, et al.: Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006, 27:1229–1235.

    Article  PubMed  CAS  Google Scholar 

  48. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, et al.: Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006, 129:1459–1467.

    Article  PubMed  Google Scholar 

  49. Alajmi M, Mulgrew AT, Fox J, et al.: Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007, 185:67–72.

    Article  PubMed  CAS  Google Scholar 

  50. Bazzano LA, Khan Z, Reynolds K, et al.: Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417–423.

    Article  PubMed  CAS  Google Scholar 

  51. Haentjens P, Van Meerhaeghe A, Moscariello A, et al.: The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007, 167:757–764.

    Article  PubMed  Google Scholar 

  52. Martinez-Garcia MA, Gomez-Aldaravi R, Soler-Cataluna JJ, et al.: Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J 2007, 29:951–957.

    Article  PubMed  CAS  Google Scholar 

  53. Morgan BJ, Dempsey JA, Pegelow DF, et al.: Blood pressure perturbations caused by subclinical sleep-disordered breathing. Sleep 1998, 21:737–746.

    PubMed  CAS  Google Scholar 

  54. Marin JM, Carrizo SJ, Vicente E, et al.: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046–1053.

    PubMed  Google Scholar 

  55. Gotsopoulos H, Kelly JJ, Cistulli PA: Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep 2004, 27:934–941.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barbara J. Morgan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dopp, J.M., Reichmuth, K.J. & Morgan, B.J. Obstructive sleep apnea and hypertension: Mechanisms, evaluation, and management. Current Science Inc 9, 529–534 (2007). https://doi.org/10.1007/s11906-007-0095-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-007-0095-2

Keywords

Navigation